Scott Smith | Senior Vice President and Chief Financial Officer |
Jan Mikkelsen | President and Chief Executive Officer |
Mark Bach | Head-Clinical Development and Medical Affairs for Endocrinology Rare Diseases |
Jesper Høiland | Global Chief Commercial Officer |
Dana Pizzuti | Head-Development Operations |
Jessica Fye | JPMorgan |
Michelle Gilson | Canaccord Genuity |
Andrew Anido | SVB Leerink |
Tazeen Ahmad | Bank of America |
David Lebovitz | Morgan Stanley |
Jim Birchenough | Wells Fargo |
Alethia Young | Cantor |
Leland Gershell | Oppenheimer |
Ladies and gentlemen, thank you for standing by, and welcome to the Third Quarter 2020 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to hand the conference over to your speaker today, Scott Smith, Senior Vice President and Chief Financial Officer at Ascendis Pharma. Please go ahead, sir.
Thank you, operator.